Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.
“Esmolol hydrochloride is a beta 1 -selective (cardioselective) adrenergic receptor blocking agent with rapid onset, a very short duration of action and no significant intrinsic sympathomimetic or membrane stabilising activity at therapeutic dosages.”
“Esmolol hydrochloride has a rapid distribution half-life of about 2 minutes and an elimination half-life of about 9 minutes.”
Working under the parallel aged-care framework? Aged-care equivalent →